Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
The promising results of a phase II clinical study for Akeso's Cadonilimab (PD-1/CTLA-4) combined standard treatment for first-line treatment of R/M cervical cancer has been published in Clinical Cancer Research 2024-02-28 17:27
Results of three investigator-initiated trials on cadonilimab (PD-1/CTLA-4) for G/GEJC, pMMR/MSS mCRC, and HCC neoadjuvant therapy published at ESMO Asia 2023 2023-12-05 21:00
Lenovo Visuals Business Unit Cements Status as Industry Leader 2019-10-18 08:30
Lenovo and Microsoft Deepen Strategic Ties across Devices 2016-08-23 07:57
1